Enter your email address below to receive ButtonwoodResearch.com's daily market update. You will receive FREE daily commentary, Top Gainer and Biggest Loser, and Market Analysis for Equity Investors, Swing …
Biogen Inc (NASDAQ:BIIB)’s share price rose 4.3% during mid-day trading on Thursday following a stronger than expected earnings report, MarketBeat.Com reports. The company traded as high as $279.40 and last traded …
Earnings
Biogen Idec and other NASDAQ stock quotes are delayed by at least 20 minutes. All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at …
Stock rating for biopharmaceutical company Biogen Inc. (NASDAQ:BIIB) was maintained as Market Perform by analyst Geoffrey Porges at Leerink Partners. The reiteration in the rating came after company’s disclosure of …
TCC5mon
Biogen Inc. (NASDAQ: BIIB), is in the industry Biotechnology. Based in USA, Biogen Inc. has a market cap of 62842.16. Therefore, Biogen Inc. is a large market cap stock. Today it is currently trading at 291.03 (0.31%), …
NASDAQ
InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading TipsInvestors have a tough task of separating Biogen's issues, much of which are PR-related, to make a bull case for the BIIB stock.The post …
Biogen Idec Inc (NASDAQ:BIIB) has had their stock rating reaffirmed as a solid Outperform by investment analysts at Wells Fargo. This was unveiled in a comprehensive report on Friday morning. From a total of 14 …
Biogen Idec Inc. (NASDAQ:BIIB) has been given a sentiment score of 0.416 by research firm. Coming to the sentiment scale, the impact score measured on daily basis stands on a 1-100 scale. This score is taken into …
NEW YORK (Reuters) - Biogen Inc (O:BIIB) on Tuesday won an intellectual property rights ruling against hedge fund manager Kyle Bass over its top …
Biogen Idec
Biogen Inc (NASDAQ:BIIB) touched a two-year low of $232.16 earlier, but was last seen 2.3% higher at $238.28. The stock's intraday rebound may be connected to a brokerage note from Baird, which presents the biotech …